Self-Care Training for Caregiver Stress
(MCP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of this treatment for reducing caregiver stress?
Research shows that mindfulness and compassion practices can effectively reduce stress, improve emotional regulation, and enhance self-care in healthcare settings. Mindfulness training has also been found to alleviate psychological distress and improve quality of life in chronic illness management, and a pilot study demonstrated its feasibility and effectiveness in improving mindfulness among caregivers of veterans.12345
Is mindfulness-based stress reduction safe for caregivers?
How does the treatment for caregiver stress differ from other treatments?
This treatment is unique because it combines mindfulness meditation and psychoeducation to help caregivers manage stress, which is different from traditional treatments that may not focus on mindfulness. Mindfulness meditation helps caregivers become more aware of their thoughts and feelings, potentially reducing stress and improving resilience, while psychoeducation provides them with knowledge and skills to better handle caregiving challenges.1011121314
What is the purpose of this trial?
The purpose of this study is to assess whether an 8-week mindfulness program enhances psychological well-being (e.g., stress, depressive symptoms), biological indicators of stress (e.g., inflammation), and cognitive function (e.g., attentional ability) in primary family caregivers of persons with dementia or a related neurodegenerative disease. A total of 232 primary family caregivers aged 50+ years of age will be recruited for this study and randomized to one of three groups: mindfulness meditation (MM), psychoeducation (PSY) or caregiver respite (CR). All participants will complete three testing sessions: baseline (pre-intervention \[T1\]), post 8-week follow-up (post-intervention, \[T2\]), and 12-month follow-up (T3).
Research Team
Alexandra Fiocco, PhD
Principal Investigator
Toronto Metropolitan University
Eligibility Criteria
This trial is for primary family caregivers aged 50 or older who are caring for someone with dementia or a similar disease. They must speak English fluently and be able to attend all sessions. Caregivers already practicing mindfulness, those with PTSD, substance disorders, psychosis, or without computer/internet access cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in an 8-week program, either mindfulness meditation, psychoeducation, or receive respite care
Post-intervention Follow-up
Participants are assessed for psychological well-being, biological stress indicators, and cognitive function
Long-term Follow-up
Participants are monitored for long-term effects on psychological well-being, biological stress indicators, and cognitive function
Treatment Details
Interventions
- Mindfulness Meditation
- Psychoeducation
- Wait list control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Toronto Metropolitan University
Lead Sponsor